Abiopharma

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Directors Interest in Securities

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Directors Interest in Securities

New Form PX14A6G - GENERAL MILLS INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001214659-26-010867 <b>Size:</b> 38 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041522 <b>Size:</b> 475 KB

Sabanto Appoints Agriculture Technology Veteran John M. Raines to its Board of Directors

(87% Neutral) MICRON TECHNOLOGY INC (MU) Announces Business Combination

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024857 <b>Size:</b> 1 MB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Directors Interest in Securities

New Form NPORT-P - Ares Dynamic Credit Allocation Fund, Inc. <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001410368-26-085976 <b>Size:</b> 407 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041521 <b>Size:</b> 760 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024856 <b>Size:</b> 589 KB

(55% Neutral) CPI CARD GROUP INC. (PMTS) Announces Business Combination

StepStone Group Closes its Infrastructure Secondaries Fund, Raising $1.7 Billion Across the Fund and Related Separate Accounts

Candel Therapeutics to Present at September Investor Conferences

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041519 <b>Size:</b> 356 KB